Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC (Q84465877)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21713366%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21713366%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

main subject

hepatocellular carcinoma

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21713366%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

6

Rudolf Jung

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21713366%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

8

Arndt Hartmann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21713366%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Karl Quint

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21713366%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Abbas Agaimy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21713366%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Roberta Montalbano

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21713366%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Claudia Steindorf

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21713366%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Claus Hellerbrand

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21713366%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Helmut Sitter

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21713366%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Daniel Neureiter

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21713366%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Matthias Ocker

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21713366%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

publication date

29 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21713366%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21713366%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

459

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21713366%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21713366%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

129-139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21713366%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00428-011-1103-0

6 February 2020

exact match

0 references

cites work

Development of molecularly targeted therapies in hepatocellular carcinoma: where do we go now?

1 reference

12 December 2020

Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma: correlation with poor prognosis with possible regulation

1 reference

12 December 2020

Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo

1 reference

12 December 2020

Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1

1 reference

12 December 2020

Biomarkers in drug discovery and development

1 reference

12 December 2020

The histone-deacetylase inhibitor SAHA potentiates proapoptotic effects of 5-fluorouracil and irinotecan in hepatoma cells

1 reference

12 December 2020

Immunohistochemical detection of histone deacetylases in endometrial carcinoma: involvement of histone deacetylase 2 in the proliferation of endometrial carcinoma cells

1 reference

12 December 2020

The histone-deacetylase inhibitor MS-275 and the CDK-inhibitor CYC-202 promote anti-tumor effects in hepatoma cell lines.

1 reference

12 December 2020

High histone deacetylase 7 (HDAC7) expression is significantly associated with adenocarcinomas of the pancreas.

1 reference

12 December 2020

Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA

1 reference

12 December 2020

Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells

1 reference

12 December 2020

Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis.

1 reference

12 December 2020

Histone deacetylase-1 and -3 protein expression in human breast cancer: a tissue microarray analysis

1 reference

12 December 2020

[Histopathological diagnose of non-alcoholic and alcoholic fatty liver disease]

1 reference

12 December 2020

Hepatocellular carcinoma

1 reference

12 December 2020

Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies

1 reference

12 December 2020

Biomarkers for novel targeted therapies of hepatocellular carcinoma

1 reference

12 December 2020

Deacetylase inhibitors - focus on non-histone targets and effects

1 reference

12 December 2020

Histone deacetylase inhibitors: signalling towards p21cip1/waf1.

1 reference

12 December 2020

The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma

1 reference

12 December 2020

Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer.

1 reference

12 December 2020

High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo

1 reference

12 December 2020

The pan-deacetylase inhibitor panobinostat inhibits growth of hepatocellular carcinoma models by alternative pathways of apoptosis.

1 reference

12 December 2020

Expression of class I histone deacetylases indicates poor prognosis in endometrioid subtypes of ovarian and endometrial carcinomas

1 reference

12 December 2020

HDAC expression and clinical prognosis in human malignancies

1 reference

12 December 2020

Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma.

1 reference

12 December 2020

Molecular therapy for the treatment of hepatocellular carcinoma

1 reference

12 December 2020

GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis

1 reference

12 December 2020

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

12 December 2020

Epidemiology of Hepatocellular Carcinoma

1 reference

12 December 2020

Expression of class I histone deacetylases (HDAC1 and HDAC2) in oesophageal adenocarcinomas: an immunohistochemical study

1 reference

12 December 2020

10.1007/S00428-011-1103-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21713366%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference